State of the Art Screening and Surveillance for Gastrointestinal Cancer 2019

Topics

• Identifying patients who will most benefit from routine screening for GI malignancy
• Clinical importance of screening and surveillance for major GI cancers, including neoplasms of the esophagus, stomach, colon, rectum, liver and pancreas
• Newly available tumor markers and predictive models
• Including individuals with premalignant lesions and genetic predispositions
• Metrics of quality that can be applied to GI screening and surveillance practice

Who should Attend

• Endoscopists
• Gastroenterologists
• Surgeons
• Endosonographers
• Nurses
• Oncologists
• Other healthcare professionals